Cargando…
Challenging issues in molecular-targeted therapy
There are variety of anticancer treatments including chemotherapeutic drugs, which are known to induce cell growth arrest and apoptosis through DNA damage and cytoskeleton toxicity. Meanwhile, histone deacetylase (HDAC) inhibitors could apply their antitumor activity through chromatin remodeling and...
Autor principal: | Ezziane, Zoheir |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697511/ https://www.ncbi.nlm.nih.gov/pubmed/19436605 |
Ejemplares similares
-
Contemporary research in quantum systems
por: Ezziane, Zoheir
Publicado: (2014) -
Molecular Docking and Analysis of Survivin Delta-Ex3 Isoform Protein
por: Ezziane, Z
Publicado: (2008) -
Challenges and solutions to nicotine replacement therapy access: observations from SCIMITAR+
por: Arundel, Catherine E., et al.
Publicado: (2020) -
Uptake of NHS health check: issues in monitoring
por: Riley, Victoria A., et al.
Publicado: (2018) -
Procollagen-Like Protein as a Molecular Target in the Treatment of Primary Brain Tumor
por: Wangpaichitr, Medhi, et al.
Publicado: (2002)